Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved by Israel’s Ministry of Health
— Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated…
— Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated…
CAMBRIDGE, Mass., April 04, 2023 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the…
Helping the Council for Economic Education Build Life Skills Nationwide NEW YORK–(BUSINESS WIRE)–#CEE—Ray Dalio, New…
Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) is now approved in the EU for use…
Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) is now approved in the EU for use…
Experienced business executive to help establish the Company as a significant force in the field…
Experienced business executive to help establish the Company as a significant force in the field…
Results from three participants demonstrated no incidence of acute rejection at durations of 56, 154,…
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line Image: GreenLight Biosciences…
`Four patients enrolled in open-label Phase 1b kidney transplant trial with clinical data on first…
WILMINGTON, Del.–(BUSINESS WIRE)–A new survey from WSFS Bank, the primary subsidiary of WSFS Financial Corporation…
Exclusive NYSE event kicks off multi-year program to advance economic equality so women don’t have…
The BIIB080 Phase 1b clinical study is the first to show a reduction of this…
The BIIB080 Phase 1b clinical study is the first to show a reduction of this…
Libtayo-based combination demonstrated superior survival outcomes compared to chemotherapy alone in Phase 3 trial designed…
Libtayo-based combination demonstrated superior survival outcomes compared to chemotherapy alone in Phase 3 trial designed…
GreenLight’s RTP greenhouse facility in North Carolina GreenLight’s RTP greenhouse facility in North Carolina Two…
— Results In-Line with March 20 Preannouncement — — Issues FY23 Guidance with Expectation for…